Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SRC1 Antibody (N-term) Blocking Peptide | Login | SRC1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK10 Antibody (N-term) Blocking Peptide | Login | MAPK10 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK11 Antibody (Center) Blocking Peptide | Login | MAPK11 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK12 Antibody (Center) Blocking Peptide | Login | MAPK12 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| STK11 (LKB1) Antibody (N-term V34) Blocking peptide | Login | STK11 (LKB1) Antibody (N-term V34) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| SCYL3 Antibody (N-term) Blocking Peptide | Login | SCYL3 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| SCYL3 Antibody (C-term) Blocking Peptide | Login | SCYL3 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (N-term G37) Blocking Peptide | Login | AKT1 Antibody (N-term G37) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK1 Antibody (T184) Blocking Peptide | Login | MAPK1 Antibody (T184) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT2 Antibody (C-term) Blocking Peptide | Login | AKT2 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT2 Antibody (Center) Blocking Peptide | Login | AKT2 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT2 Antibody (S474) Blocking Peptide | Login | AKT2 Antibody (S474) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT3 Antibody (C-term) Blocking Peptide | Login | AKT3 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK3 Antibody (T202) Blocking Peptide | Login | MAPK3 Antibody (T202) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAPK3 Antibody (Y204) Blocking Peptide | Login | MAPK3 Antibody (Y204) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CDK7 Antibody (N-term K42) Blocking Peptide | Login | CDK7 Antibody (N-term K42) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PDK1 Antibody (N-term) Blocking Peptide | Login | PDK1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| Rictor Antibody (N-term) Blocking Peptide | Login | Rictor Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PDK1 (PDPK1) Antibody (N-term H67) Blocking peptide | Login | PDK1 (PDPK1) Antibody (N-term H67) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| PDK1 (PDPK1) Antibody (C-term) Blocking peptide | Login | PDK1 (PDPK1) Antibody (C-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| PDPK1 Antibody (S396) Blocking Peptide | Login | PDPK1 Antibody (S396) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| DYRK1A Antibody (N-term) Blocking Peptide | Login | DYRK1A Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| DYRK1A Antibody (Center) Blocking Peptide | Login | DYRK1A Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| SRC1 Antibody (C-term) Blocking Peptide | Login | SRC1 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| Aromatase (CYP19A1) Antibody (C-term) Blocking peptide | Login | Aromatase (CYP19A1) Antibody (C-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||


